Transarterial chemoembolization plus lenvatinib with or without protein-1 inhibitor for hepatocellular carcinoma with portal vein tumor thrombus

Figure 4 Univariate and multivariate analysis. A: Overall survival after propensity score matching; B: Univariate and multivariate analysis of progression-free survival after propensity score matching. AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; HbsAg: Hepatitis B surface antigen; HR: Hazard ratio; TACE-L: Transarterial chemoembolization combined with lenvatinib; TACE-L-P: Transarterial arterial chemoembolization combined with lenvatinib plus death protein-1 inhibitors; TBIL: Total bilirubin.